Products
Tools
Education
$7.50
$7.15
$18.55
$3.86
$238.4M
43.43%
This is a preview of the full version of Prosperse
PepGen Inc. (PEPG) stock dropped over 45% after the company released data from its ongoing Phase 2 trial. Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of PepGen investors.
Bronstein, Gewirtz & Grossman, Llc
Aug 13, 2024
Date: Oct 25, 2024
Date: Oct 24, 2024